2m 2m 2m 2m 2m 2m 2m
Pacira BioScienc (PCRX)
NASDAQ
$36.65+$0.19 (+0.52%)
Price as of Nov 12, 2026 8:21 AM EST- $1.5BMarket Cap
- 52.81%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Pacira BioScienc (PCRX)
$36.65+$0.19 (+0.52%)
PCRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $36.46 | ||
Change | -$0.03 (-0.08%) | ||
Open | $36.48 | ||
High | $36.50 | ||
Low | $36.45 | ||
Previous Close | $36.49 | ||
Volume | 945,464 | ||
30-Day Average Volume | 1,195,189 | ||
1-Week Change | 0.16% | ||
1-Month Change | 0.41% | ||
1-Year Change | 52.81% | ||
3-Year Change | 28.02% | ||
5-Year Change | -35.82% | ||
Fundamentals | |||
Shares Outstanding | 39.9M | ||
Total Assets | $1.2B | ||
Market Cap | $1.5B | ||
Enterprise Value | $1.5B | ||
Period: QTR TTM FY | |||
Revenue | $175.4M | ||
Net Income | $28.5M | ||
Free Cash Flow | $46.4M | ||
EBIT | $31.7M | ||
EBITDA | $51.0M | ||
Net Working Capital | $464.1M | ||
EPS | $0.70 | ||
Enterprise Value/EBITDA | 30 | ||
Enterprise Value/Revenue | 9 | ||
P/B | 2 | ||
P/E | 52 | ||
PEG | 0 | ||
Price/Free Cash Flow | 31 | ||
Price/Operating Cash Flow | 29 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue